Gladstone and Stanford In Collaboration to Develop Induced Pluripotent Stem (IPS) Cells for Cardiac Therapies
Gladstone and Stanford In Collaboration to Develop Induced Pluripotent Stem (IPS) Cells for Cardiac Therapies
SAN FRANCISCO, CA—November 1, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine t